EW Healthcare Partners

EW Healthcare Partners is a healthcare growth equity firm that has been pursuing and supporting growth companies since 1985. With strategically located investment offices in New York, London, and Houston, they share a global perspective and an understanding of the evolving healthcare landscape. The firm focuses on making growth equity investments in fast-growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and Europe. Their investment strategy is driven by the increasing demand for enhanced healthcare, innovative technology, and improved healthcare products, influenced by factors such as an aging population, rising prevalence of chronic diseases, and the adoption of innovative technologies and therapies. EW Healthcare Partners has invested globally since 2000, with currently active investments in Europe, China, and Latin America. Their portfolio includes companies like Abiomed, Biotoscana, Bioventus, and EUSA Pharma. The firm has raised over $4 billion since inception and has been a long-term investor in over 150 healthcare companies, ranging across sectors, stages, and geographies. The team comprises over 20 senior investment professionals with offices in New York, Houston, and London. Their approach emphasizes partnering with highly experienced management teams to build best-of-breed businesses, providing capital and guidance to accelerate growth for the benefit of all stakeholders and patients. EW Healthcare Partners' extensive experience and global reach enable them to identify and pursue growth equity investments that align with their mission to drive positive change in the healthcare industry for patients and communities worldwide.